Q1 Earnings Estimate for Innospec Issued By Seaport Res Ptn

Innospec Inc. (NASDAQ:IOSP - Free Report) - Analysts at Seaport Res Ptn raised their Q1 2025 earnings estimates for Innospec in a note issued to investors on Monday, April 21st. Seaport Res Ptn analyst M. Harrison now expects that the specialty chemicals company will post earnings of $1.39 per share for the quarter, up from their previous forecast of $1.38. Seaport Res Ptn currently has a "Strong-Buy" rating on the stock. The consensus estimate for Innospec's current full-year earnings is $6.18 per share.

Separately, StockNews.com lowered shares of Innospec from a "buy" rating to a "hold" rating in a report on Wednesday, April 2nd.

Innospec Trading Down 0.9 %

NASDAQ:IOSP traded down $0.77 during mid-day trading on Wednesday, hitting $89.03. The stock had a trading volume of 43,555 shares, compared to its average volume of 148,799. Innospec has a twelve month low of $80.32 and a twelve month high of $133.71. The stock has a 50-day simple moving average of $94.61 and a two-hundred day simple moving average of $106.96. The company has a market capitalization of $2.24 billion, a PE ratio of 62.88 and a beta of 1.03.

Innospec (NASDAQ:IOSP - Get Free Report) last posted its quarterly earnings results on Tuesday, February 18th. The specialty chemicals company reported $1.41 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.36 by $0.05. Innospec had a return on equity of 12.27% and a net margin of 1.93%. The company had revenue of $466.80 million for the quarter, compared to analyst estimates of $447.43 million.

Institutional Investors Weigh In On Innospec

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Pacer Advisors Inc. purchased a new stake in shares of Innospec in the 4th quarter valued at about $53,457,000. Raymond James Financial Inc. acquired a new position in Innospec during the fourth quarter worth approximately $20,992,000. Norges Bank acquired a new position in Innospec during the fourth quarter worth approximately $11,312,000. JPMorgan Chase & Co. lifted its stake in Innospec by 24.6% in the third quarter. JPMorgan Chase & Co. now owns 266,688 shares of the specialty chemicals company's stock valued at $30,160,000 after buying an additional 52,640 shares during the last quarter. Finally, Barclays PLC boosted its holdings in shares of Innospec by 357.1% in the third quarter. Barclays PLC now owns 44,559 shares of the specialty chemicals company's stock valued at $5,039,000 after acquiring an additional 34,811 shares during the period. 96.64% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Innospec news, VP Philip John Boon sold 3,754 shares of the stock in a transaction that occurred on Friday, February 21st. The shares were sold at an average price of $103.30, for a total value of $387,788.20. Following the transaction, the vice president now directly owns 20,079 shares in the company, valued at $2,074,160.70. This represents a 15.75 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP Corbin Barnes sold 2,692 shares of the business's stock in a transaction that occurred on Friday, February 21st. The stock was sold at an average price of $103.30, for a total transaction of $278,083.60. Following the sale, the senior vice president now owns 8,051 shares of the company's stock, valued at $831,668.30. This represents a 25.06 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 7,696 shares of company stock valued at $794,853 in the last ninety days. Insiders own 1.31% of the company's stock.

Innospec declared that its Board of Directors has approved a share repurchase plan on Monday, March 10th that allows the company to repurchase $50.00 million in outstanding shares. This repurchase authorization allows the specialty chemicals company to purchase up to 2% of its shares through open market purchases. Shares repurchase plans are often a sign that the company's board of directors believes its stock is undervalued.

About Innospec

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.